PMID: 2440311Jul 1, 1987Paper

Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor

The American Journal of Physiology
J B Smith, T M Lincoln

Abstract

Atrial natriuretic factor (ANF) produced rapid increases in cyclic GMP (cGMP) in cultured aortic smooth muscle cells. Angiotensin II (ANG II) markedly decreased the accumulation of cGMP that was evoked by ANF. Arginine vasopressin and ATP, which evoke transient increases in free Ca2+ similarly to ANG II, also inhibited cGMP accumulation. The effect of the calcium mobilizing neurohormones was mimicked by the divalent cation ionophore, A23187. The cyclic nucleotide phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, prevented ANG II from inhibiting ANF-evoked cGMP accumulation. ANG II also inhibited cGMP accumulation induced by nitroprusside, a compound that activates cytosolic guanylate cyclase. These findings support the hypothesis that ANG II decreases cGMP accumulation by stimulating cGMP hydrolysis, apparently via a Ca2+-activated cGMP phosphodiesterase.

References

Nov 15, 1985·Biochemical and Biophysical Research Communications·J B SmithG R Pettit
Dec 14, 1984·Biochemical and Biophysical Research Communications·Y HirataM Ikeda
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R J WinquistR M Rapoport
Nov 1, 1982·Molecular and Cellular Endocrinology·J A BeavoM C Mumby
Sep 17, 1984·Biochemical and Biophysical Research Communications·J B Smith, L Smith

❮ Previous
Next ❯

Citations

May 1, 1992·Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Für Medizinische Physik and the European Federation of Organisations for Medical Physics·G DoughertyS J Pettinger
Jun 1, 1988·Journal of the Optical Society of America. A, Optics and Image Science·J M Steinke, A P Shepherd
Aug 15, 1996·Annals of the New York Academy of Sciences·M PonsJ M Waterhouse
Aug 1, 1997·Journal of Hypertension·M B Anand-Srivastava
Jul 31, 1998·The New England Journal of Medicine·E R LevinW K Samson
Feb 22, 2007·Kidney & Blood Pressure Research·Eun Hui BaeSoo Wan Kim
Jul 1, 1997·Toxicology and Industrial Health·R P BrownR P Beliles
Oct 16, 1999·Proceedings of the Association of American Physicians·H H Chen, J C Burnett
Sep 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S M NarayanA W Toga
Sep 12, 2000·Current Cardiology Reports·H H Chen, J C Burnett
Sep 16, 2000·Current Opinion in Nephrology and Hypertension·J C Burnett
Jul 2, 1999·British Journal of Cancer·T J DunnM W Dewhirst
Jan 12, 2001·The Journal of Biological Chemistry·L R Potter, T Hunter
Aug 20, 2003·European Journal of Clinical Investigation·A CharlouxB Geny
Oct 30, 2008·Optics Express·Yulia M SerebrennikovaLuis H García-Rubio
Nov 14, 2007·Shock·Sen CuiYasutaka Kurata
Oct 1, 1988·Applied Optics·J M Steinke, A P Shepherd
Sep 16, 1998·The Anatomical Record·B TandlerC J Phillips
Jul 1, 1996·Molecular and Cellular Biochemistry·M AradB Rabinowitz
Oct 1, 1994·Chronobiology International·M PonsJ Cambar
Feb 28, 2009·Journal of Physiology and Biochemistry·M GarcíaJ J Calvo
Feb 15, 2008·Applied Optics·A M NilssonS Andersson-Engels
Jan 29, 2011·Journal of Biomedicine & Biotechnology·Zaid AbassiAaron Hoffman
Dec 13, 2006·Biomedizinische Technik. Biomedical Engineering·Martina MeinkeMoritz Friebel
Nov 19, 2013·Pflügers Archiv : European journal of physiology·Jeong Hee HongShmuel Muallem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.